CTKB EBITDA Growth
Cytek Biosciences Inc · EBITDA Growth
CTKB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-148.35%period ending
CTKB Quarterly EBITDA YoY % (224.82% → -148.35%)
Year-over-year change
High-resolution chart · PNG
CTKB ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -148.3546% | |
| -76.7149% | |
| 89.2784% | |
| -236.6288% | |
| 26.2248% | |
| -32.8135% | |
| -135.3968% | |
| 399.2241% | |
| -22.2133% | |
| 7.219% | |
| 3.976% | |
| -131.5291% | |
| -3,440.1786% | |
| -428.2381% | |
| 311.1659% | |
| 20.8872% | |
| -97.1289% | |
| -279.1066% | |
| -80.9069% | |
| -61.783% | |
| 1,001.9774% | |
| 224.8201% |